Major Medical Devices Appoints Eric Curtis as CEO

January 21, 2026—Major Medical Devices, Inc. (MMD), an emerging developer in vascular intervention technologies for abdominal aortic aneurysm (AAA), announced the appointment of Eric Curtis as its Chief Executive Officer (CEO).

MMD stated that its AAA technology, which is designed to enable upper extremity access for endovascular aneurysm repair (EVAR), has shown encouraging early data in preclinical studies, that reinforces its planned timeline for wider clinical evaluation.

According to MMD, Curtis is an expert in product development, capital raise, business development, and commercialization with 26 years of experience in the health care industry.

Curtis commented, “I am pleased to join MMD as the company’s CEO. I believe medical device innovation in AAA treatment is needed and MMD’s next-generation device could become the next standard of care in a condition that impacts 35 million patients worldwide. MMD has a team of experts in vascular surgery, development, technology and design, raising capital, intellectual property, and business development.”

He continued, “I believe the company has the team talent and the innovative product in development to be successful, especially because the team developed the device, called Axses, from learning and addressing key areas for the device to be differentiated from competition including an ultra-low-profile design with upper extremity access.”

He added, “I believe there are unique opportunities with Axses including the potential to treat AAA patients who are excluded from current EVAR treatment because they have smaller arteries, calcification, tortuous vessels or concerns with femoral access. MMD is poised to quickly develop Axses for AAA patients, and I welcome investors to contact me to learn more.”